Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol.11, no.4, pp.288-292, 2015 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 11 Issue: 4
- Publication Date: 2015
- Doi Number: 10.1111/ajco.12358
- Journal Name: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.288-292
- Keywords: metastatic renal cell carcinoma, platelet to lymphocyte ratio, prognosis, CARCINOMA, SURVIVAL, INFLAMMATION, SORAFENIB
- Akdeniz University Affiliated: Yes
Abstract
AimThe objective of this study was to evaluate the blood platelet-lymphocyte ratio (PLR) for its prognostic value in patients with metastatic renal cell cancer (RCC).